EnteroMedics, Inc. (ETRM) – Buzz Stock of the Day

Posted on Tuesday, June 22nd, 2010

Shares of medical device maker, EnteroMedics, Inc. (Nasdaq: ETRM) soared 75 percent from Monday’s closing price, in morning trading on Tuesday after the company announced positive data from an ongoing feasibility study of the Maestro System in obese patients with Type-2 diabetes mellitus. The study was designed to evaluate the safety and efficacy of the Company’s next-generation Maestro RC System, which treats obesity.

James Toouli, M.D., professor of surgery at Flinders University in Adelaide, Australia, and one of the study’s investigators said the results from the study showed “significant, sustained improvements in glycemic control and blood pressure as well as clinically meaningful weight loss, without a compromise in patient safety.”

[–quote–]

Data from the Empower study, in which over 400 patients have used the Maestro System device, showed significant weight loss and control of obesity related co-morbidities.

EnteroMedics’ device, which is implanted laparoscopically, blocks the vagus nerves periodically using high-frequency, low-energy electrical impulses.

“Across a number of studies, we have observed clinically significant weight loss and control of obesity related co-morbidities as well as a safety profile that distinguishes this system from all other bariatric surgical procedures. We are particularly encouraged by the strong, positive feedback from the metabolic and bariatric surgery community,” said EnteroMedics’ President and CEO Mark B. Knudson, Ph.D in a statement.


EF Johnson Technologies, Inc. (EFJI) – Buzz Stock of the Day

Posted on Monday, June 21st, 2010

Shares of communications service provider, EF Johnson Technologies, Inc. (Nasdaq: EFJI) were up 40 percent from Friday’s close in morning trading on Monday after the company announced that an affiliate of Francisco Partners will acquire all of the outstanding shares of EF Johnson Technologies’ common stock for $1.50 per share in cash. The new offer represents a 42 percent increase over the $1.05 per share cash purchase price contemplated by the parties’ original merger agreement previously announced on May 17, 2010.

The merger was unanimously approved by EF Johnson Technologies’ board of directors.

[–quote–]

“Our amended merger agreement with Francisco Partners provides increased all-cash premium value to our stockholders and reflects Francisco Partners’ strong commitment to the transaction,” said Michael E. Jalbert, Chairman of the Board and Chief Executive Officer of EF Johnson Technologies, Inc. in a statement. “We are proud of the value we have delivered to our stockholders through this amended merger agreement, and are excited to work closely with Francisco Partners to complete the transaction as expeditiously as possible.”

EF Johnson Technologies’ communications product portfolio includes Project 25 compliant two-way radios, P25 compliant trunked and conventional infrastructure systems, voice encryption modules for all brands of analog two-way radios, and FIPS 140-2 Validated™ secure wireless broadband, mesh and WLAN solutions. The company’s customers include the US Army, US Air Force, US Navy, US Department of Homeland Security, US Coast Guard, and FEMA, to name a few.

Shares of EFJI are up about 53 percent over the past three months.


Penny Buzz Stocks to Watch on 6/18 – CWLZ, MILV, MYSL

Posted on Friday, June 18th, 2010

Here are a few penny stocks we’re watching on Friday, June 18:

Cowlitz Bancorp. (Nasdaq: CWLZ): Shares of Cowlitz Bancorp. were up a staggering 84 percent from Thursday’s close in morning trading on Friday. Cowlitz Bancorporation operates as the holding company for Cowlitz Bank that provides a range of financial services to small and medium-sized businesses, professionals, and retail customers.

Mistral Ventures, Inc. (Pink Sheets: MILV): Shares of Mistral Ventures, Inc. were up 25 percent in morning trading on Friday. Earlier this month, Mistral Ventures announced an asset purchase agreement to buy substantially all the assets, proprietary products, licenses, and operations of telecom company, Tech World Capital, Inc., d.b.a. Tech World, Inc. for an aggregate of 940 Million restricted 144 shares in the Capital of the Company representing a change of control. The agreement between the two companies was mutually rescinded yesterday.

My Screen Mobile, Inc. (Pink Sheets: MYSL): Shares were up almost 23 percent from Thursday’s close in morning trading on Friday. My Screen Mobile, which develops mobile advertising technology platforms, yesterday announced that it completed a second stage of the financing arrangement previously announced with Global Financial Enterprises LLC. The company also recently launched its new interactive mobile advertising technology in Argentina with Claro, a large mobile communications network in those countries, and a subsidiary of America Movil S.A. de C.V. BMV: AMX(NYSE: AMX, NASDAQ: AMOV, LATIBEX: XAMXL).


Molecular Insight Pharmaceuticals, Inc. (MIPI) – Buzz Stock of the Day

Posted on Friday, June 18th, 2010

Shares of oncology-focused biotech, Molecular Insight Pharmaceuticals, Inc. (Nasdaq: MIPI) were up more than 28 percent in morning trading on Friday.

Last week, the Cambridge-based Molecular Insight Pharmaceuticals presented nonclinical data demonstrating the utility of the Company’s novel radiopharmaceutical compounds for the molecular imaging of prostate and other tumors at the Society of Nuclear Medicine (SNM) annual meeting in Salt Lake City.

[–quote–]

“Molecular Insight has established a deep pipeline of novel radio-imaging and radiotherapeutic compounds capable of binding to specific disease-related changes at the cellular level for a given cancer for highly targeted results,” said John W. Babich, Ph.D., Executive Vice President, Chief Scientific Officer, and President of Research and Development for Molecular Insight Pharmaceuticals, Inc.

Molecular Insight also announced the receipt of SNM’s 2010 Berson-Yalow Award for a nonclinical study demonstrating the potential of Molecular Insight’s compound 99mTc-MIP-1340 to provide accurate imaging of metastatic prostate cancer. 99mTc-MIP-1340 is a small molecule inhibitor of PSMA for molecular imaging of prostate cancer. Preclinical results have confirmed that 99mTc-MIP-1340 binds specifically and with high affinity to PSMA and accumulates in human prostate cancer xenografts.

Other notable biotech for this week include: Neurocrine Biosciences, Inc. (Nasdaq: NBIX), Celgene Corp. (Nasdaq: CELG) and CardioNet, Inc. (Nasdaq: BEAT). Biotech could be a bright spot in the market this year, according to some experts.


Shot Spirits Corp. (Pink Sheets: SSPT) – Micro-cap Buzz Stock

Posted on Thursday, June 17th, 2010

For all you sub-penny stock traders, keep an eye on Shot Spirits Corp. (Pink Sheets: SSPT). Shares were up almost 92 percent on heavy volume in morning trading on Thursday after the company announced a deal with American Express, “which further positions GuestMetrics™ IP as a compelling advantage in an industry which turns over three trillion dollars a year,” according to Shot Spirits CEO, Brian Barrett.

[–quote–]

GuestMetrics provides a “unifiedied view into the behavior of  guests and the performance of your business,” according to the Company’s Web site. “GuestMetrics tools are fully and seamlessly integrated with your point-of-sale system (POS) so they can: capture table-level purchase information from the point of sale;  combine guest information with detailed business operations data across multiple locations and POS systems; and create detailed reports through in-depth analysis.

According to today’s news release, GuestMetrics™ is currently in discussions with a worldwide hospitality provider with hotels, resorts and conference centers as just a handful of its brands.  At the same time, Shot Spirits Corp’s Shot Spirits International is confident it will be enjoying another strong quarter in its partnership with the revolutionary, Eco-friendly Beverage Pouch Group.

“It’s simply amazing technology and extremely valuable to those in highly competitive industries such as hospitality and the prepaid (credit and debit card) industry,” said Barrett. “IP is hard to get your head around sometimes.  It’s invisible; but the output is compelling to say the least. We’re thrilled that AMEX recognizes this as we feel GuestMetrics data tracking abilities will become an indispensable tool for various industries as we continue to expand our capabilities and IP applications.”